S. 481 · 114th Congress

Improving Regulatory Transparency for New Medical Therapies Act

Stage: Reported from committee
Sponsor: Orrin Hatch
Introduced: 2015-02-12
Latest action: 2015-10-01 · Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

Subjects

Administrative law and regulatory procedures

Health

Licensing and registrations

Drug therapy

Department of Health and Human Services

Intellectual property

Drug safety, medical device, and laboratory regulation

Food and Drug Administration (FDA)

Drug trafficking and controlled substances

Veterinary medicine and animal diseases